Answers are grounded in this paper and cite their sources.
Objective Neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery is increasingly used in advanced endometrial cancer patients not amenable for primary surgery. However, validated biomarkers to predict treatment response and surgical outcomes remain lacking.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: